The National Institutes of Health (NIH) is offering a grant opportunity titled "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)". This grant aims to support pilot, feasibility, or exploratory research in substance use epidemiology and health services. The research will focus on five priority areas, including responses to sudden and severe emerging drug issues, responses to emerging marijuana trends and topics related to the shifting policy landscape, responses to unexpected and time-sensitive prescription drug abuse research opportunities, responses to unexpected and time-sensitive medical system issues, and responses to unexpected and time-sensitive criminal or juvenile justice opportunities that relate to drug abuse and access and provision of health care service.

The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities, U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Institutions) and non-domestic components of U.S. Organizations are not eligible to apply.

The grant does not require cost sharing or matching requirements. The funding instrument type is a grant, and the category of funding activity is health. The maximum award ceiling is $275,000.

The deadline for application submission is September 8, 2024. For more information and to apply, please visit the following link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-027.html. If you have any inquiries, you can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.